Stocks
Cassava Sciences Inc (SAVA) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -4.96 | -7.14 | -32.9 | -80.0 | -104.4 | -98.7 | ||
| Changes by years, y/y, % | -26% | +44% | +360% | +143% | +31% | +73.4% | |||
Cassava Sciences Inc. EBITDA US GAAP, bln rub
Cassava Sciences Inc. EBITDA US GAAP, changes, %
Cassava Sciences Inc. EBITDA US GAAP, sum by quarters, bln rub
Cassava Sciences Inc (SAVA) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -26.5 | -28.8 | -27.9 | -22.4 | -19.6 | -98.7 | |
| Changes by years, y/y, % | +51% | +44% | +31% | +7% | -26% | |||
| Changes by quarters, q/q, % | +27% | +9% | -3% | -20% | -13% | |||
